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Abstract:  
Uniparental disomy (UPD), the inheritance of both homologues of a chromosome from only 
one parent, has been reported for nearly all human chromosomes. Depending on its mode 
of formation and time of occurrence, UPD can be present in all cells of an organism, or 
restricted to some cell lines as a mosaic UPD. Though its general frequency is unknown, it 
becomes clinically relevant when it produces homozygosity for recessive pathogenic 
variations or is associated with chromosomal imbalances. UPDs are well-known for their 
connection to imprinting disorders. Beyond its clinical and diagnostic significance, detection 
of UPD has value for research in the identification of putative disease mechanisms and 
genomic regions of interest. Furthermore, detection of UPD in a cluster of similar clinical 
cases can lead to the definition of new genetic syndromes and imprinted loci, thereby 
elucidating imprinting regulation and epigenetic mechanisms in general. In this review, we 
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focus on UPDs originating from meiotic and early postzygotic nondisjunction events and 
their relevance to imprinting disorders.  
Keywords  
Uniparental disomy; chromosomal non-disjunction; trisomic rescue; monosomic rescue; 
genomic Imprinting; mosaicism; imprinting disorders; UPD 
 
1. Introduction 
Uniparental disomy (UPD), the inheritance of both homologues of a chromosome from only 
one parent, was first proposed by Eric Engel in 1980 [1], however, another eight years passed 
before the first case of UPD was reported [2]. Depending on the mode of formation and time of 
occurrence, UPD can be present in all cells of an organism or restricted to some cell lines as mosaic 
UPD. In a variety of human cancers, acquired UPD is a common molecular event leading to 
homozygosity for tumor suppressor genes as well as oncogenes [3].  
UPD has pathological significance as it can result in homozygosity for pathogenic gene 
variations. The term “isozygosity” is used to describe homozygosity of a recessive variant when 
inherited from the same parent and will be used throughout this review. UPD can also be 
associated with chromosomal disturbances, UPD can also be associated with chromosomal 
disturbances, but they are most well-known for their association with imprinting disorders. The 
identification of UPD in Prader-Willi syndrome (PWS) patients in 1989 [4] demonstrated the 
importance of UPD in the understanding of genomic imprinting. 
In this review, we will focus on UPDs originating from meiotic and early postzygotic 
nondisjunction events and their relevance for imprinting disorders and their elucidation. 
2. Definition and Formation Mechanisms 
Unlike normal biparental transmission, UPD occurs when both chromosome homologues are 
inherited from a single parent. An individual with both homologous chromosomes (genetically 
different) from the same parent is said to have uniparental heterodisomy (UPhD), whereas 
deriving homologous (genetically identical) chromosomes from the same parent is referred to as 
uniparental isodisomy (UPiD). Heterodisomy typically occurs as a result of meiosis I nondisjunction, 
while isodisomy is typically due to a meiosis II nondisjunction or a mitotic error. Mixed forms of 
UPiD/UPhD or UPhD/UPiD are also possible (Figure 1a). Furthermore, UPDs can be present with or 
without chromosomal aberrations, which include mosaic trisomy, translocations, and 
isochromosomes [5]. UPDs can involve a whole chromosome or can be segmental, where only part 
of a chromosome is inherited from the same parent. Additionally, the whole chromosome 
complement (whole genome) can be derived from one parent (uniparental diploidy), either from 
the mother or from the father. The term “genome-wide UPD” is commonly used in literature, but 
we suggest using the term “uniparental diploidy” instead.  
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Figure 1 Example mechanisms of UPD formation. (a) Four scenarios leading to whole 
chromosome UPDs. In the figure, only monosomy rescue for maternal UPD is shown; 
paternal UPD is caused by monosomy rescue following fertilization between nullisomic 
oocyte and normal sperm. Paternal chromosomes are shown in black; maternal 
homologous chromosomes are striped. Small horizontal ellipses depict centromeres. 
UPhD, uniparental heterodisomy; UPiD, uniparental isodisomy. (b) Mechanism leading 
to segmental UPD. (c) UPD mechanisms in the offspring of Robertsonian translocation 
carriers. The mother is carrier of t (14; 22) translocation, while the father has normal 
karyotype. Chromosome 22 is shown in black (paternal) or gray (maternal). Maternal 
homologue chromosomes 14 are shown in red and pink, and paternal chromosomes 
14 in dark and light blue.  
2.1. Mechanisms of Whole Chromosome UPD Formation 
Whole chromosome UPDs occur via four main mechanisms (Figure 1a). The first three 
mechanisms originate in meiosis and are a corrective response to aneuploidy.  Human oocytes are 
markedly prone to aneuploidy, particularly with increasing maternal age [6] and in association 
with defects in meiotic crossover [7]; premature separation is suggested as the major segregation 
error [8]. Uniparental disomy represents a potential mechanism for aneuploidy rescue and 
likewise shows increasing frequency with maternal age [9, 10].   
Trisomic rescue. Trisomic rescue happens when a meiotic nondisjunction occurs in one of the 
conceiving gametes resulting in disomy and a subsequent trisomic conceptus after fertilization. 
The trisomy is corrected by non-random elimination of the extra chromosome (trisomic rescue); if 
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the remaining chromosomes are from the same parent, this will result in uniparental disomy 
(UPD). Depending on whether the nondisjunction occurred during meiosis I or II, the UPD can be 
heterodisomic (UPhD) or isodisomic (UPiD), respectively (if we assume recombination between 
sister chromatids has not occurred). Mixed UPhD/UPiD or UPiD/UPhD (the centromere are within 
the heterodisomic region, and the centromere are within the isodisomic region, respectively) are 
caused by recombination between the sister chromatids of a pair of the homologous 
chromosomes of the disomic conceiving gamete (Figure 1a). UPhD/UPiD, with heterodisomic 
markers around the centromere and isodisomic markers near the telomere, indicates a meiosis I 
error, whereas UPiD/UPhD with isodisomic markers around the centromere and heterodisomic 
markers near the telomere indicates a meiosis II error (Figure 1a). If the trisomic rescue occurs in a 
later postzygotic stage, this will result in a mosaic UPD case [11]. 
Monosomic rescue. In this model, nondisjunction during meiosis I in one of the conceiving 
gametes results in nullisomy and in a monosomic conceptus after fertilization. Monosomic rescue 
takes place in the early postzygotic stage by replication of the monosomic chromosome, leading to 
UPiD.  
Postfertilization (mitotic) error. In this case the conceptus is disomic. A mitotic error can lead to 
a monosomy or trisomy that can be corrected through monosomic or trisomic rescue, respectively, 
and may lead to isodisomic UPD in both scenarios.   
Gamete complementation. This mechanism requires simultaneous occurrence of meiotic 
disjunction in both gametes, where one is nullisomic and the other is disomic, leading to UPhD in 
the conceptus. If a recombination had occurred between the sister chromatids of a pair of the 
homologous chromosomes of the disomic conceiving gamete, this will lead to mixed UPiD/UPhD 
(centromere is within the isodisomic region) or UPhD/UPiD (centromere is within the 
heterodisomic region) (Figure 1a). 
2.2. Mechanisms of Segmental UPD Formation 
Segmental UPD is one of the main molecular alterations observed in Beckwith-Wiedemann 
syndrome [12]. It is suggested to result from a postzygotic mitotic cross-over between the 
paternal and maternal homologue chromosomes and in principle can only be a segmental 
isodisomy (Figure 1b). An alternative mechanism is trisomic rescue as described above, where a 
mitotic recombination between paternal and maternal homologue chromosomes occurs before 
the “normal” extra chromosome is discarded from the cell. In this mechanism, segmental UPD can 
be both isodisomic and heterodisomic. Segmental UPD can also be mosaic [12].   
2.3. Mechanisms for Uniparental Diploidy  
Only mosaic uniparental diploidy conceptuses are viable and most of these are of paternal 
origin [13, 14]; only one single case of maternal uniparental diploidy has been described in 
literature [15]. Four different mechanisms have been suggested for mosaic uniparental diploidy 
occurrence and were described in detail by Kalish et al. [13].  
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2.4. UPDs Accompanied by Chromosome Aberrations 
UPD cases may arise due to translocations [5]. Different scenarios have been proposed for the 
formation of UPD in the offspring of the carriers of balanced translocations, including 
Robertsonian translocations (Figure 1c) [5]. The karyotypes of these offspring may be balanced or 
unbalanced. In one of these scenarios, the chromosome aberration of the offspring with UPiD is an 
isochromosome (homologous Robertsonian translocation), which likely occurs from a monosomic 
rescue. Notably, upd(14) and upd(15) are the most frequently reported UPDs associated with 
Robertsonian translocations [5], but this might be due to the fact that the majority of 
Robertsonian translocations affect chromosome 14 and that clinical pictures are only associated 
with UPDs of these chromosomes; UPDs of chromosomes 13, 21, and 22 have not yet been 
reported as clinically relevant (Table 1). 
UPDs can also be accompanied by small supernumerary marker chromosomes and the 
formation mechanisms are explained in detail by Liehr [5]. 
Table 1 Congenital imprinting disorders associated with UPDs 
Chromosome Maternal UPD Paternal UPD 
6 Imprinting phenotype or result of 
trisomy 6 mosaicism? 
Transient neonatal Diabetes mellitus 
7 Silver-Russell syndrome Overgrowth? 
11 Silver-Russell syndrome Beckwith-Wiedemann syndrome 
14 Temple syndrome Kagami-Ogata syndrome 
15 Prader-Willi syndrome,  Angelman syndrome 
16 Imprinting phenotype or result of 
trisomy 16 mosaicism? 
 
20 Mulchandani-Bhoj-Conlin 
syndrome (upd(20)mat) 
Pseudohypoparathyroidism Ib 
In ten of the 13 UPDs, the role of disturbed imprinting as the cause for the associated 
phenotypes is evident, but in three it is in discussion (in italics). 
3. Epidemiology 
Maternal and paternal UPDs have been described for all human chromosomes except 19 and Y, 
and more than 3,600 cases with UPDs in developmental disorders are documented [16]. In the 
majority of UPDs, no specific phenotypes are associated with the aberrant constitution, but an 
association with clinical pictures has been shown for ten UPDs (Table 1), which are distinguished 
as imprinting disorders.   
The total frequency of all UPDs (including whole chromosome and segmental UPDs) is unknown, 
because (a) there have been no systematic studies to determine its prevalence, (b) UPDs without 
clinical consequences are not identified, and (c) UPD mosaicism cannot readily be detected using 
standard diagnostic algorithms. In fact, the majority of UPDs have been identified adventitiously in 
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individuals with clinical features or indications for UPD testing (e.g. imprinting disorders and 
specific chromosomal variants). 
Through extrapolation of UPD frequency of chromosome 15, Robinson suggested the general 
incidence of UPD as 1:3,500 [6]. Its incidence appears increased in patients exhibiting intellectual 
disability, developmental delay, dysmorphisms, and congenital anomalies. In 2010, Conlin et al. 
[17] reported on eight patients with (segmental) UPD among 2019 patients (0.39%). A similar ratio 
was determined in a larger cohort of 14,574 patients by Wang et al. [18], who identified a UPiD in 
0.13% (n = 19), and a mixed UPhD/UPiD or segmental UPD in 0.17% (n = 25).  
More recently, further estimates have been based on array analyses. Using chromosome 
microarray data from 173 trios, Sasaki et al. [19] estimated a rate of approximately 0.6% for 
segmental UPDs. In a cohort of 14,574 patients with a broad range of clinical indications, Wang et 
al. [18] identified 25 cases with significant regions of homozygosity of a single chromosome. In five 
of those patients, mixed UPhD/UPiD could be confirmed, and in 2 patients a segmental UPD was 
identified. In the remaining cases UPD was suspected. Thus, an incidence of less than 1% in 
patients with clinical features can be assumed. However, this data is limited by a defined 
restriction of a region of homozygosity of ≥5 Mb [18]; therefore, segmental UPiDs/UPhDs with a 
size of less than 5 Mb escape detection. 
Chromosome-specific frequencies of UPDs are difficult to estimate as there are strong 
ascertainment biases. An example is upd(15)mat:  it is overwhelmingly overrepresented in reports 
on UPD because upd(15)mat accounts for 70-75% of Prader-Willi syndrome (PWS) occurences, a 
condition that is well-known in pediatrics and therefore frequently tested. In contrast, upd(15)pat 
is less frequently documented as it accounts for only 1-2% of the mutation spectrum in Angelman 
syndrome (AS), an imprinting disorder with a similar prevalence as PWS. This ascertainment bias is 
obvious in the studies of Conlin et al. and Wang et al. [17, 18], where a considerable number of 
UPDs were upd(15)mat. However, two further UPD constitutions, upd(7)mat and upd(14)mat, are 
frequently published although the associated disorders are rare. Many groups working in the field 
of imprinting disorders have recently focused on these specific alterations and have screened for 
specific clinical cohorts. 
Aside from imprinting disorders, UPDs are also associated with chromosomes affected by 
trisomy. For example, trisomy 16 (with maternal origin of the supernumerary chromosome) is one 
of the most common aneuploidies detected during human prenatal development; while it persists 
in growing placenta, it is incompatible with fetal development and therefore is reduced by trisomy 
rescue to give a relatively high frequency of upd(16)mat in liveborn offspring [14]. 
In summary, the current observed frequency of UPDs is determined by the observance of 
clinical consequences and associations with other chromosomal aberrations, but is likely not 
accounting for UPDs that do not have clinical presentations. It is likely to hypothesize that the 
actual frequency of UPDs is higher than the current observed frequency. 
4. Risk Factors for UPD Formation Following Meiotic and Early Postzygotic Nondisjunction 
Individuals who are at risk to carry UPDs are (a) children born to older mothers, (b) children 
from pregnancies with chromosomal aneuploidy mosaicism in the extraembryonic tissues, and (c) 
carriers of (familial) structural variants or their offspring (i.e. Robertsonian translocations or 
marker chromosomes). 
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The association of UPD with advanced maternal age can be explained by the increased risk of 
trisomy formation of older mothers and the subsequent trisomic rescue, which is the major mode 
of UhPD formation (Figure 1). This association only applies to maternal UPhD, however it can be 
assumed that increased maternal age is the major risk factor for UPD formation. Its relevance has 
already been proven for several UPDs (e.g. upd(20)mat and upd(16)mat [20, 21]). In contrast, 
paternal UPDs and UPiDs should not be influenced by maternal age in theory, and this has been 
confirmed for upd(7)mat where the maternal age in the UPhD subcohort is higher than in the UPiD 
group [22].  
Trisomy rescue also explains the occurrence of UPD in pregnancies with chromosomal 
aberrations detected during prenatal development. Trisomy rescue can typically be detected by 
prenatal identification of a trisomy in a chorionic villous sample followed by identification of a 
disomy in a subsequent amniocentesis. This mechanism was first documented in 1992 for 
chromosome 15, with a with a 47, +15 karyotype at chorionic villous sampling, a normal karyotype 
in amniocentesis, and a upd (15) mat in the newborn [23, 24]. It is therefore recommended to test 
fetuses of pregnancies with trisomic cells in chorionic villous sampling for UPD, at least for those 
with a clinical relevance [25]. 
Carriers of (balanced) structural chromosomal variants or their offspring have an increased risk 
for UPD (see above). In this category, Robertsonian translocations affecting acrocentric 
chromosomes are the most frequent structural variants in humans (incidence in the general 
population: 0.1%). Robertsonian translocations involving chromosomes 14 and 15 lead to 
increased risk of four imprinting disorders in affected families. These types of translocations gave 
the first clues towards the identification of the imprinted region in 15q11-q13 and the associated 
imprinting disorders PWS and AS [26]. It also subsequently allowed the identification of the 
chromosome 14-associated imprinting disorders [27, 28]. However, translocations other than the 
acrocentric chromosomes should be regarded as risk factors for UPD formation, as documented by 
several case reports [29]. In families with a known translocation or a prenatal detection of a 
variant, UPD testing is suggested if there is evidence for involvement of a chromosome containing 
imprinted genes, i.e. chromosomes 6, 7, 11, 14, 15,and 20 [25]. Another group of structural 
variants which might be associated with UPD are small supernumerary marker chromosomes, 
however, this combination has rarely been reported [30, 31]. Regardless, UPD testing should be 
considered in cases where clinical features are compatible with an imprinting disorder, or when 
chromosomes containing imprinted genes are involved. 
The identification of structural variants underlying UPD is essential to give accurate genetic 
counselling of recurrence risk. In families with structural chromosomal variants, there may be 
elevated risk not only for UPD, but also for unbalanced chromosomal rearrangements.  
5. UPDs and Their (Patho) Physiological Significance 
Though UPDs themselves do not alter the karyotype or DNA sequence, they can be associated 
with an aberrant phenotype due to the three following mechanisms.  
5.1. UPDs and Genomic Imprinting 
Genomic imprinting is the restriction of gene expression potential by parent of origin [32]. 
Approximately 40 human genomic regions evade epigenetic reprogramming in the early embryo, 
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and thus faithfully maintain the epigenetic programming of the egg or sperm. As a result, at key 
developmental times and places the expression of imprinted genes is functionally hemizygous. 
Disturbance of this epigenetically-balanced gene expression at certain loci gives rise to imprinting 
disorders (Figure 2).  
In a UPD affecting an imprinted locus, methylation is faithfully maintained. As both alleles are 
from the same parent, no expression of the imprinted genes within this locus occurs, leading to 
disturbance of the overall balance of methylation and therefore gene expression. 
 
 
Figure 2  Example of imprinting regulation utilizing the imprinted regions on chr11p15. 
The upper panel represents normal biparental inheritance at the closely apposed 
imprinted loci on chr11p15.  The lower panel represents paternal UPD, where the 
balance of imprinted gene expression is disturbed via downregulation of H19 and 
CDKN1C and upregulation of IGF2. Maternally and paternally expressed genes are 
shown with red and blue horizontal blocks, respectively. Filled lollipops, methylated 
CpG sites; empty lollipops, unmethylated CpG sites. Arrows show direction of 
transcription, and Ω symbols represent micro-RNA binding sites. 
5.2. UPDs and Chromosomal Aberrations/Structural Variants 
The phenotype of UPD carriers can be influenced by a co-occurring trisomy or structural variant. 
In this situation, the UPD is regarded as a biomarker for the chromosomal alteration (e.g. 
upd(6)mat and upd(16)mat) [20, 33] rather than as the cause of the aberrant phenotype. 
Moreover, the combination of both chromosomal alterations and UPDs can cause heterogeneous 
clinical presentations, obscuring clinical diagnosis or mimicking known disorders. 
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5.3. UPDs as Cause of Unexpected Homozygosity for Recessive Mutations - Isozygosity 
Apart from the UPDs of chromosomes harboring imprinted genes (Table 1), maternal and 
paternal UPDs of other chromosomes have been identified by chance, either as coincidental 
findings by genotyping assays (SNP arrays and NGS) in research or diagnostic contexts (e.g. GWAS 
in research context and molecular karyotyping in diagnostics), or in patients with unexpected 
isozygosity by linkage and mutation analysis. In these families, only one of the parents is a 
heterozygous carrier, and the child is homozygous due to UPiD. In fact, this was the case in the 
first proven patient with UPD, suffering from cystic fibrosis due to maternal UPiD of chromosome 
7 and homozygosity for a CFTR variant [2]. UPiD can be restricted to the region harboring the gene 
affected by the pathogenic variant or affect the whole chromosome. In many cases, the UPiD has 
been identified after discovery of the homozygous pathogenetic variant, but identification of UPiD 
can also be the first step in the detection of a candidate gene and the pathogenic mutation [18]. 
6. UPDs and Their Clinical Significance 
According to the aforementioned pathomechanisms, UPDs can affect phenotype by the 
homozygosity of a recessive allele or an associated chromosomal disturbance. In the latter case, 
UPD can be regarded as one molecular type out of a variety of molecular pathomechanisms on a 
genomic level that result in the gene and mutation-specific phenotype. 
Because of their association with imprinting disorders, UPDs have clinical signficance (Table 2). 
Imprinting disorders are a group of rare human congenital diseases with prevalences less than 
1:10,000 among newborns. These disorders are caused by changes in both gene sequences 
(“genetic variations,” which include UPDs) and gene regulation (“epigenetic variations”), affecting 
parentally-imprinted loci. To date, twelve clinically-recognized disorders have been defined and 
characterized by common underlying molecular mechanisms and overlapping phenotypes; in ten 
of these UPDs have been identified [32]. Clinical features primarily appear prenatally or in early 
childhood, and nearly all of them have a severe impact on health including abnormal growth, 
tumor development, disturbed metabolism, neurodevelopmental delay, and precocious puberty. 
They include well-known congenital disorders like PWS, AS, Beckwith-Wiedemann, and Silver-
Russell syndrome, as well as rare disorders that are lesser-known such as transient neonatal 
diabetes mellitus; pseudohypoparathyroidism; or the recently described Temple, Kagami-Ogata, 
Schaaf-Yang, and Mulchandani-Bhoj-Conlin syndromes. Recently, upd(6)mat, upd(16)mat, and 
upd(7)pat have been suggested to be associated with imprinting disorders [20, 33, 34]. However, 
the influence of trisomy 6 or 16 mosaicism on the phenotype has been suggested for upd(6)mat 
and upd(16)mat, based on the genetic findings and the clinical heterogeneity of the carriers.  
Due to the clinical heterogeneity of imprinting disorders and their ambiguity to physicians, 
patients often experience a delay in diagnosis, or remain without diagnosis. As a result, the 
prevalence of imprinting disorders among newborns are currently unknown and can be only 
roughly estimated. The frequent presence of non-specific features and the phenotypic overlaps 
between the different disorders as well as variance in diagnoses challenges the accurate diagnosis 
of imprinting disorders (Table 2). In addition, the classification of imprinting disorders is becoming 
increasingly complex, causing further complexity in diagnosis and leading to uncertainty for 
patients and families, as well as healthcare providers. 
 
OBM Genetics 2018; 2(3), doi:10.21926/obm.genet.1803031 
 
Page 11/19 
Table 2 Summary of the most frequent and overlapping features in imprinting disorders 
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Transient 
neonatal 
diabetes 
mellitus 
+ Retardation NR + ? + + - -/? ? 
upd(6)mat + Retardation ? ? ? + + -/? -/? ? 
Silver-Russell 
syndrome 
+ Retardation NR +   + -/+ -/? + + 
Birk Barel 
mental 
retardation 
+ NR NR -/? ? + + + -/? ? 
Beckwith-
Wiedemann 
syndrome 
+ Overgrowth ≤20% + ? -/+ - + -/? + 
Temple 
syndrome 
+ Retardation NR + -/+ + -/+ -/+ + + 
Kagami-Ogata 
syndrome 
+ Overgrowth + + ? + + + -/? + 
Prader-Willi 
syndrome 
+ Retardation NR + + + + + - -/? 
Angelman 
syndrome 
- Normal NR -/? ? -/+ + + - -/? 
precoious 
puberty 
- Normal NR -/? ? - - - + -/? 
Shaaf-Yang 
syndrome 
+ ? NR + ? + + + - -/? 
upd(16)mat ? Retardation ? -/ ? ? +/? +/? ? -/? + 
Pseudo-
hypopara-
thyreodism 
+ Retardation ? ? -/+ - + + NR + 
upd(20)mat + Retardation NR NR ? + -/+ -/+ ? -/? 
(- not present; + present; NR not reported but possible; ? unknown or reported in rare 
cases, therefore making an association questionable) 
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7. UPD as a Tool for Research 
Beyond its diagnostic significance, detection of UPD has been valuable for research:  (a) its 
detection during genome-wide genetic diagnosis can suggest a new disease mechanism and a 
genomic region of interest, (b) detection in a cluster of similar clinical cases can lead to defining 
new genetic syndromes, and (c) aiding in the identification of imprinted genes. 
7.1. Adventitious Detection Suggesting Disease Mechanisms and Their loci  
Identification of UPDs has been a significant by-product of genetic diagnosis from its inception.  
For example, the first association of UPD with Silver-Russel syndrome occured during discovery of 
recessive cystic fibrosis [2, 35]; the diagnosis of cystic fibrosis continues to provide clarification of 
the gene(s) involved with SRS on chr7 [36].   
Additionally, the current large-scale genomic medicine initiatives offer a very welcome 
opportunity to detect UPD [37].  Moreover, researchers and diagnosticians across the world ought 
to continue to share these rare diagnoses, in order to identify clusters of similar individuals (see 
below). In some cases, UPD may be coincidental to clinical presentation, or may be a 
manifestation of another disease mechanism. For instance, cases in literature describe UPD in 
association with clinical presentations [34, 37]; time will tell whether these descriptions will 
develop into new clinical UPD disorders, represent coincidental findings, or reveal recessive 
disorders.   
7.2. Clustering of Cases with Similar Clinical Presentations and Shared UPD May Lead to The 
Recognition of New Clinical Syndromes 
An example of a specific syndrome that originated from a cluster of cases with similar clinical 
presentations is the isolated syndromic presentation of upd(14)mat. Although it was first 
described in 1991 [28], it was recently recognized as a distinct syndrome and named Temple 
syndrome (TS14) [38, 39], and has a degree of phenotypic overlap with both PWS and SRS [40].  
Defining the clinical parameters of TS14 led to refinement of its genetic etiology [41], and it is now 
routinely identified in association with CNVs, UPD, and epimutations (i.e. aberrant methylation 
marks without obvious alteration of the DNA sequence) of the imprinted gene cluster on chr14q32. 
A similar process of clinical clustering and syndrome definition is in progress with upd(20)mat [21, 
42], which ought to refine its genetic etiology.   
7.3. With the Advent of Genome-wide DNA Methylation Analysis, DNA from Individuals with 
UPD has Been Used to Identify Imprinted Genes 
Comparative analysis, such as genome-wide DNA methylation analysis, can either use DNA 
from numerous individuals with UPD of different chromosomes[43], uniparental diploidy [44], or 
nonviable imprinting errors such as hydatidiform moles and ovarian teratomas [45]. These 
analyses have yielded what can reasonably be claimed as a comprehensive list of germline-
imprinted genes (i.e. genes where the imprinting marks are established in the gametes), which has 
been invaluable in understanding the mechanisms and pathologies of imprinting. Notably, 
placental imprinting and its pathologies are relatively less understood [46]. 
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8. Methods to Identify UPD 
The appropriate tools to identify UPDs are DNA-based polymorphic markers (Table 3). In 
contrast, tests visualizing chromosomes (including conventional karyotyping), fluorescence in situ 
hybridization (FISH), and chromosome microarrays (SNP-arrays or array CGH) for detection of copy 
number variants (CNVs), are not suitable to detect UPDs; these can only suggest chromosomal 
constitutions prone to UPD formation, like trisomy mosaicism or structural variants which might 
result in UPD (e.g. t(14;14) [25]). 
In principle, UPDs can be identified by all techniques that can detect the genotyping of 
polymorphic markers (Figure 3).  
 
 
Figure 3 Identification of UPD by molecular genetic testing. (a, b) Identification of 
upd(7)mat by microsatellite typing and methylation-specific MLPA: (a) Typing results of 
the marker D7S460 reveals a UPiD, whereas typing results for D7S2446 correspond to a 
UPhD. Please note that the typing result of D7S460 does not allow the discrimination 
between UPiD and a deletion of the paternal allele. (b) By MS-MLPA, a deletion of the 
imprinted genes GRB10 (7p13) and MEST (7q32) could be excluded by copy number 
analysis (upper row), but methylation analysis (lower row) does not discriminate 
between upd(7)mat and isolated hypermethylation (epimutation). (c) Identification of 
a UPiD of chromosome 9 by SNP array analysis (Cytoscan® HD, Affymetrix, Santa 
Clara/CA, USA): (1) large stretches of loss of heterozygosity indicate a uniparental 
isodisomy for these regions. (2) Distributi on of SNP (light green) and oligo probes 
(dark green). (3) Physical map of chromosome 9. 
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Table 3 Methods applicable for identification and proof of UPDs and other molecular changes in imprinting disorders. 
Method Identification of Number of  
tested loci 
Advantages Disadvantages 
UPD CNVs Epimutation 
Microsatellite analysis 
(microsatellits/short tandem 
repeatR typing) 
Yes Yes No Single loci Fast, cheap DNA sample of at least one parent required, 
in case of homozygosity of one allele: no 
discrimination between UPD and CNV 
possible 
SNP (single nucleotide 
polymorphism)array (molecular 
karyotyping) 
Isodisomy, 
(heterodiso
my) 
Yes No Whole genome High resolution; covering 
the whole genome; 
identification of 
segmental UPDs 
Expensive; identification of heterodisomy 
requires testing of parents and specific 
bioinformatic tools 
Methylation specific methods 
(PCR, Multiplex Ligation-
dependent Probe 
Amplification/MLPA, 
pyrosequencing, bisulfite 
sequencing, Southern blot…) 
Yes Yes Yes Single or limited 
number of loci 
Detects all molecular 
changes disturbing the 
methylation pattern 
Discrimination of the three molecular 
subtypes often not possible; final proof of 
UPD requires MSA typing  
High throughput methylation-
specific tests (arrays, next 
generation sequencing) 
Yes Yes Yes Whole genome High resolution; covering 
the whole genome; 
identification of 
segmental UPDs 
Expensive; requires comprehensive 
bioinformatic tools; currently not applicable 
in diagnostic workup  
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These can be highly polymorphic markers like microsatellites (also referred to as short tandem 
repeats) or single nucleotide variants. The classical tool utilized to identify UPDs is microsatellite 
typing, and it has been determined that two informative markers (meaning that both parents are 
heterozygous for different alleles) are sufficient to confirm a UPD [25]. Microsatellite typing is 
based on PCR-based amplification of highly polymorphic repeats (e.g. CA repeats or trinucleotide 
repeats), followed by high-resolution gel electrophoresis. It includes parallel analysis of DNA 
samples of the patient and at least one parent. In the case of a positive testing result, both 
parental samples should be included, and paternity should be confirmed for maternal UPD. 
Microsatellite typing is well-established in routine diagnostic labs as it requires basic molecular 
laboratory equipment and is therefore fast and cheap. It is currently utilized as the major test in 
the diagnosis of UPD, however high-throughput genotyping techniques (such as SNP array analysis) 
are growing in significance. The advantage of this test is that thousands of SNP markers on one 
chromosome are analyzed, thereby even small segmental UPDs as well as uniparental diploidy are 
detectable. However, the identification of UPhD needs analyses of parental samples and specific 
software tools [47], which is much more expensive than microsatellite analysis.   
In the case of specific chromosomes that contain imprinted loci, methylation-specific (MS) tests 
can provide indirect evidence for a UPD. As illustrated in Figure 3, MS multiplex ligation-
dependent probe amplification (MS-MLPA) is a suitable assay to identify disturbed methylation 
patterns, with the advantage that it addresses copy number variations and methylation marks in 
one assay, and can target more than 40 loci. However, it should be noted that MS-MLPA, like 
other MS assays (Table 3), can identify copy number variations, epimutations, and UPD, but might 
not discriminate epimutations from UPD.  
Nevertheless, molecular diagnostic testing is currently being revolutionized by the 
implementation of NGS-based assays, which also affects UPD testing. In the future, the choice of 
which method to apply will depend on the indication: in the case of targeted UPD testing, e.g. in 
families with Robertsonian translocations, short tandem repeat typing might be sufficient, 
whereas in nonspecific phenotypes, array or NGS testing might be indicated. 
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